LIN28A-Dependent Kinome and Phosphoproteome Reprogramming Promotes Imatinib Resistance
Owen F.J. Hovey, Mallory I. Frederick, Quan M. Quach, Jenica H. Kakadia, Alyssa Wu, Kyle Yang, Tingting Wu, Xiang Ruan, Tomonori Kaneko, Courtney Voss, Ilka U. Heinemann, Shawn S.‐C. Li
This study identifies LIN28A as a mediator of imatinib resistance in CML by reprogramming the kinome and phosphoproteome, with potential therapeutic implications for overcoming resistance.
Molecular & Cellular Proteomics · Jan 20, 2026Peer-reviewedCancer Biology